<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1028-9933</journal-id>
<journal-title><![CDATA[Revista Información Científica]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. inf. cient.]]></abbrev-journal-title>
<issn>1028-9933</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas Guantánamo]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1028-99332022000400004</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Factores de riesgo asociados a pacientes con colitis microscópica]]></article-title>
<article-title xml:lang="en"><![CDATA[Risk factors associated with patients with microscopic colitis]]></article-title>
<article-title xml:lang="pt"><![CDATA[Fatores de risco associados a pacientes com colite microscópica]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Clavel-Rosales]]></surname>
<given-names><![CDATA[Reyner]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ricardo-Serrano]]></surname>
<given-names><![CDATA[Yoel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cabrera-Lavernia]]></surname>
<given-names><![CDATA[Jorge Omar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martí-Garcés]]></surname>
<given-names><![CDATA[Gloria Mabel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Peláez-Llorente]]></surname>
<given-names><![CDATA[Maythe]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital General Provincial &#8220;Carlos Manuel de Céspedes&#8221;  ]]></institution>
<addr-line><![CDATA[ Granma]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Ciencias Médicas de Granma Facultad de Ciencias Médicas de Bayamo ]]></institution>
<addr-line><![CDATA[ Granma]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2022</year>
</pub-date>
<volume>101</volume>
<numero>4</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1028-99332022000400004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1028-99332022000400004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1028-99332022000400004&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  La primera descripción de la colitis microscópica se realizó en el año 1976. Actualmente, agrupa tres subgrupos de patologías, las clásicas colitis linfocítica y colitis colagenosa, el tercer subgrupo corresponde a la colitis microscópica incompleta.  Objetivo: Identificar los principales factores asociados al desarrollo de colitis microscópica en el Hospital General Provincial ¨Carlos Manuel de Céspedes¨, de Bayamo, Granma, en el período marzo de 2019 hasta agosto de 2021.  Método:  Se realizó un estudio observacional, analítico de casos y controles en pacientes con edad igual o mayor de 18 años con diarreas acuosas crónicas atendidos en el servicio de gastroenterología de dicho hospital, donde se estudiaron las variables: presencia de colitis microscópica, edad, sexo, hábito de fumar, uso de medicamentos, comorbilidades, dolor abdominal, fatiga, incontinencia fecal, pérdida de peso. El tamaño de la muestra para estudios pareados se determinó mediante el programa STATA 17. Para su estimación se consideró lo siguiente: nivel de confianza, poder del estudio, relación de casos y testigos y Odds Ratio mínimo.  Resultados: No existió asociación entre la edad mayor de 50 años y la probabilidad de presentar colitis. Predominó el sexo femenino (62,5 %). Del total de pacientes con colitis microscópica (n=16) el 62,5 % fumaba. El OR obtenido indicó que los pacientes fumadores tienen 2,5 veces más riesgo. La diabetes mellitus se asoció significativamente al diagnóstico de colitis microscópica y quintuplicó el riesgo.  Conclusiones:  Existe una relación entre el sexo femenino, el hábito de fumar, la diabetes mellitus, la colecistectomía, el consumo de tres o más fármacos y la incontinencia fecal con la presencia de colitis microscópica.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  The first description of microscopic colitis was made in 1976. Currently, it groups three subgroups of pathologies, the classic lymphocytic colitis and collagenous colitis, the third subgroup corresponds to incomplete microscopic colitis.  Objective:  To identify the main factors associated with the development of microscopic colitis at the Hospital General Provincial "Carlos Manuel de Céspedes", Bayamo, Granma, from March 2019 to August 2021.  Method:  An observational, analytical study of cases and controls was carried out in patients aged 18 years or older with chronic watery diarrhea treated at the gastroenterology service. The variables studied were: presence of microscopic colitis, age, sex, smoking habit, use of medications, comorbidities, abdominal pain, fatigue, fecal incontinence and weight loss. The sample size for paired studies was determined using the STATA 17 program. For its estimation, the following were considered: confidence level, statistical power of the test, ratio of cases and controls and minimum Odds Ratio.  Results:  There was no association between age over 50 years and the probability of presenting colitis. The female sex prevailed (62.5%). Of the total number of patients with microscopic colitis (n=16), 62.5% smoked. The OR obtained indicated that smoker patients have 2.5 times more risk. Diabetes mellitus was significantly associated with the diagnosis of microscopic colitis and increased the risk fivefold.  Conclusions:  There is a relationship between female sex, smoking, diabetes mellitus, cholecystectomy, consumption of three or more drugs and fecal incontinence with the presence of microscopic colitis.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Introdução:  A primeira descrição da colite microscópica foi feita em 1976. Atualmente, agrupa três subgrupos de patologias, a colite linfocítica clássica e a colite colagenosa, o terceiro subgrupo corresponde à colite microscópica incompleta.  Objetivo:  Identificar os principais fatores associados ao desenvolvimento de colite microscópica no Hospital Geral Provincial ¨Carlos Manuel de Céspedes¨, em Bayamo, Granma, de março de 2019 a agosto de 2021.  Método:  Estudo observacional analítico de casos e controles em pacientes com 18 anos ou mais com diarreia aquosa crônica atendidos no serviço de gastroenterologia do referido hospital, onde foram estudadas as variáveis: presença de colite microscópica, idade, sexo, tabagismo, uso de medicamentos, comorbidades, dor abdominal, fadiga, incontinência fecal, perda de peso. O tamanho da amostra para estudos pareados foi determinado por meio do programa STATA 17. Para sua estimativa foram considerados: nível de confiança, poder do estudo, razão de casos e controles e Odds Ratio mínimo.  Resultados:  Não houve associação entre idade acima de 50 anos e probabilidade de apresentar colite. O sexo feminino prevaleceu (62,5%). Do total de pacientes com colite microscópica (n=16), 62,5% fumavam. A OR obtida indicou que pacientes tabagistas apresentam risco 2,5 vezes maior. O diabetes mellitus foi significativamente associado ao diagnóstico de colite microscópica e aumentou o risco em cinco vezes.  Conclusões:  Existe relação entre sexo feminino, tabagismo, diabetes mellitus, colecistectomia, consumo de três ou mais medicamentos e incontinência fecal com a presença de colite microscópica.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[colitis microscópica]]></kwd>
<kwd lng="es"><![CDATA[colitis linfocítica]]></kwd>
<kwd lng="es"><![CDATA[colitis colágena]]></kwd>
<kwd lng="es"><![CDATA[factores de riesgo]]></kwd>
<kwd lng="en"><![CDATA[microscopic colitis]]></kwd>
<kwd lng="en"><![CDATA[lymphocytic colitis]]></kwd>
<kwd lng="en"><![CDATA[collagenous colitis]]></kwd>
<kwd lng="en"><![CDATA[risk factors]]></kwd>
<kwd lng="pt"><![CDATA[colite microscópica]]></kwd>
<kwd lng="pt"><![CDATA[colite linfocítica]]></kwd>
<kwd lng="pt"><![CDATA[colite colagenosa]]></kwd>
<kwd lng="pt"><![CDATA[fatores de risco]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bauta Desdín]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Pupo Zúñigas]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Colitis microscópica]]></article-title>
<source><![CDATA[CCM]]></source>
<year>2017</year>
<volume>21</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>526-39</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prieto Ortiz]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Prieto Ortiz]]></surname>
<given-names><![CDATA[JE.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Colitis microscópica, un diagnóstico en aumento. Revisiones de tema]]></article-title>
<source><![CDATA[Rev Colomb Gastroenterol]]></source>
<year>2019</year>
<volume>34</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>339-403</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zabana]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrer]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Aceituno]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Salas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández-Bañares]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Colitis microscópica: avances para una mejor identificación en los pacientes con diarrea crónica]]></article-title>
<source><![CDATA[Gastroenterol Hepatol]]></source>
<year>2017</year>
<volume>40</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>107-16</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miehlke]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Guagnozzi]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Zabana]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Tontini]]></surname>
<given-names><![CDATA[GE]]></given-names>
</name>
<name>
<surname><![CDATA[Kanstrup Fiehn]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Wildt]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations]]></article-title>
<source><![CDATA[United Europ Gastroenterol J]]></source>
<year>2021</year>
<volume>9</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>13-37</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rojas]]></surname>
<given-names><![CDATA[BR.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnóstico y manejo de la colitis microscópica]]></article-title>
<source><![CDATA[Gastroenterol Latinoam]]></source>
<year>2019</year>
<volume>30</volume>
<numero>^ssupl 1</numero>
<issue>^ssupl 1</issue>
<supplement>supl 1</supplement>
<page-range>s35-8</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Betancourt-Vicencio]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[García-Monroy]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Garrido-Cepeda]]></surname>
<given-names><![CDATA[MEJ]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera-Ordoñez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Romero-Gómez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Latorraca-Santamaría]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Colitis microscópica: serie de casos y revisión de la bibliografía]]></article-title>
<source><![CDATA[Rev Méd MD]]></source>
<year>2019</year>
<volume>10</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>265-70</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Davidson]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sjobeig]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Engel]]></surname>
<given-names><![CDATA[PLH]]></given-names>
</name>
<name>
<surname><![CDATA[Lorinc]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Fiehn]]></surname>
<given-names><![CDATA[A-MK]]></given-names>
</name>
<name>
<surname><![CDATA[Vigren]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Microscopic colitis en Denmark and Sweden; incidence, putatne risk factor, histologred assessmeril and endoscopic activity]]></article-title>
<source><![CDATA[Scand J Gastroenterol]]></source>
<year>2018</year>
<volume>53</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>818-24</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Green]]></surname>
<given-names><![CDATA[HD]]></given-names>
</name>
<name>
<surname><![CDATA[Beaumont]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hamilton]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Wood]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Sharp]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genome-wide association stady of microscopic colitis in the UK biobank confirms immune related pathogenesis]]></article-title>
<source><![CDATA[J Crohns Colitis]]></source>
<year>2019</year>
<volume>13</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1578-82</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lyutakov]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Lozanov]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Sugareva]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Valkov]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Penchev]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serum 7 alfa-hydroxy-4 cholesten-3- one and fibroblast growth factor-19 as biomarkers diagnosing bile acid malabsorption in microscopic colitis and inflammatory bowel disease]]></article-title>
<source><![CDATA[Gastroenterol Hepatol]]></source>
<year>2021</year>
<volume>33</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>380-7</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Verhaegh]]></surname>
<given-names><![CDATA[BPM]]></given-names>
</name>
<name>
<surname><![CDATA[Vries]]></surname>
<given-names><![CDATA[F de]]></given-names>
</name>
<name>
<surname><![CDATA[Masclee]]></surname>
<given-names><![CDATA[AAM]]></given-names>
</name>
<name>
<surname><![CDATA[Keshavarzian]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Boer]]></surname>
<given-names><![CDATA[A de]]></given-names>
</name>
<name>
<surname><![CDATA[Souverein]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High risk of drug-induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors]]></article-title>
<source><![CDATA[Aliment Pharmacol Ther]]></source>
<year>2016</year>
<volume>43</volume>
<page-range>1004-13</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Law]]></surname>
<given-names><![CDATA[EH]]></given-names>
</name>
<name>
<surname><![CDATA[Badoiwski]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hung]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Weems]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[TA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association between proton pump inhibitor and microscopic colitis: Implications for practice and future research]]></article-title>
<source><![CDATA[Ann Pharmacother]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rashidian]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Muhammadnejad]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Dehpour]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Ejtemai Mehr]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Akhavan Maziar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4-KB signaling pathway]]></article-title>
<source><![CDATA[Inflammopharmacol]]></source>
<year>2016</year>
<volume>24</volume>
<page-range>109-18</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nielsen]]></surname>
<given-names><![CDATA[HL]]></given-names>
</name>
<name>
<surname><![CDATA[Dalager-Pedersen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Nielsen]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High risk of microscopic colitis after campylobacter concisus infection: population-based cohort study]]></article-title>
<source><![CDATA[Inflamm Bowel Dis]]></source>
<year>2020</year>
<volume>69</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1952-8</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kane]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Irvine]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Derwa]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Ford]]></surname>
<given-names><![CDATA[AC.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fatigue and its associated factors in microscopic colitis]]></article-title>
<source><![CDATA[Therap Adv Gastroenterol]]></source>
<year>2018</year>
<volume>11</volume>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lucendo]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández-Bañares]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Colitis microscópica y exposición a fármacos: una revisión crítica]]></article-title>
<source><![CDATA[Enferm inflam intest dia]]></source>
<year>2015</year>
<volume>14</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>94-104</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
